Such effects reveal cartilage-protective and antidematogenic effects and findings from their network pharmacological analysis showed that the NCOA4-HMGB1-GSK3B-AQPs axis may serve as a new target for osteoarthritis treatment. This evidence concerns the gene GSK3B and osteoarthritis.